Imagine having a health condition so dire that you're willing to enroll in an experimental drug trial in the desperate hope that it will bring you relief. Now imagine that, halfway through that trial, it's coming to a premature end because funding has been cut. That's the reality for thousands of Americans who have been impacted by the Trump administration's slashing of NIH grants, and it's only the beginning of the carnage that's about to be inflicted onto our healthcare system.